Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: summary guidance from CDC and the U.S. Department of Health and Human Services
- PMID: 23135062
Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: summary guidance from CDC and the U.S. Department of Health and Human Services
Abstract
This report summarizes current (as of 2011) guidelines or recommendations published by multiple agencies of the U.S. Department of Health and Human Services (DHHS) for prevention and control of human immunodeficiency virus (HIV) infection, viral hepatitis, sexually transmitted diseases (STDs), and tuberculosis (TB) for persons who use drugs illicitly. It also summarizes existing evidence of effectiveness for practices to support delivery of integrated prevention services. Implementing integrated services for prevention of HIV infection, viral hepatitis, STDs, and TB is intended to provide persons who use drugs illicitly with increased access to services, to improve timeliness of service delivery, and to increase effectiveness of efforts to prevent infectious diseases that share common risk factors, behaviors, and social determinants. This guidance is intended for use by decision makers (e.g., local and federal agencies and leaders and managers of prevention and treatment services), health-care providers, social service providers, and prevention and treatment support groups. Consolidated guidance can strengthen efforts of health-care providers and public health providers to prevent and treat infectious diseases and substance use and mental disorders, use resources efficiently, and improve health-care services and outcomes in persons who use drugs illicitly. An integrated approach to service delivery for persons who use drugs incorporates recommended science-based public health strategies, including 1) prevention and treatment of substance use and mental disorders; 2) outreach programs; 3) risk assessment for illicit use of drugs; 4) risk assessment for infectious diseases; 5) screening, diagnosis, and counseling for infectious diseases; 6) vaccination; 7) prevention of mother-to-child transmission of infectious diseases; 8) interventions for reduction of risk behaviors; 9) partner services and contact follow-up; 10) referrals and linkage to care; 11) medical treatment for infectious diseases; and 12) delivery of integrated prevention services. These strategies are science-based, public health strategies to prevent and treat infectious diseases, substance use disorders, and mental disorders. Treatment of infectious diseases and treatment of substance use and mental disorders contribute to prevention of transmission of infectious diseases. Integrating prevention services can increase access to and timeliness of prevention and treatment.
Similar articles
-
Incorporating HIV prevention into the medical care of persons living with HIV. Recommendations of CDC, the Health Resources and Services Administration, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America.MMWR Recomm Rep. 2003 Jul 18;52(RR-12):1-24. MMWR Recomm Rep. 2003. PMID: 12875251
-
Enhancing HIV/AIDS, viral hepatitis, sexually transmitted disease, and tuberculosis prevention in the United States through program collaboration and service integration: the case for broader implementation.Sex Transm Dis. 2013 Aug;40(8):663-8. doi: 10.1097/OLQ.0000000000000002. Sex Transm Dis. 2013. PMID: 23859918 Review.
-
Integrating hepatitis, STD, and HIV services into a drug rehabilitation program.Am J Prev Med. 2005 Jul;29(1):27-33. doi: 10.1016/j.amepre.2005.03.010. Am J Prev Med. 2005. PMID: 15958248
-
Recommendations for partner services programs for HIV infection, syphilis, gonorrhea, and chlamydial infection.MMWR Recomm Rep. 2008 Nov 7;57(RR-9):1-83; quiz CE1-4. MMWR Recomm Rep. 2008. PMID: 18987617
-
HIV-1/AIDS and the control of other infectious diseases in Africa.Lancet. 2002 Jun 22;359(9324):2177-87. doi: 10.1016/S0140-6736(02)09095-5. Lancet. 2002. PMID: 12090997 Review.
Cited by
-
Managing tuberculosis in people who use and inject illicit drugs.Bull World Health Organ. 2013 Feb 1;91(2):154-6. doi: 10.2471/BLT.13.117267. Bull World Health Organ. 2013. PMID: 23554532 Free PMC article. No abstract available.
-
Finding what works: identification of implementation strategies for the integration of methadone maintenance therapy and HIV services in Vietnam.Implement Sci. 2016 Apr 20;11:54. doi: 10.1186/s13012-016-0420-8. Implement Sci. 2016. PMID: 27097726 Free PMC article.
-
Hepatitis A and Hepatitis B Vaccination Coverage Among Persons Who Inject Drugs and Have Evidence of Hepatitis C Infection.Public Health Rep. 2019 Nov/Dec;134(6):651-659. doi: 10.1177/0033354919874088. Epub 2019 Sep 20. Public Health Rep. 2019. PMID: 31539482 Free PMC article.
-
Prevention and treatment produced large decreases in HIV incidence in a model of people who inject drugs.Health Aff (Millwood). 2014 Mar;33(3):401-9. doi: 10.1377/hlthaff.2013.0824. Health Aff (Millwood). 2014. PMID: 24590937 Free PMC article.
-
Low HIV testing among persons who inject drugs-National HIV Behavioral Surveillance, 20 U.S. cities, 2012.Drug Alcohol Depend. 2016 Aug 1;165:270-4. doi: 10.1016/j.drugalcdep.2016.05.024. Epub 2016 Jun 2. Drug Alcohol Depend. 2016. PMID: 27323649 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
